AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,358,000 | -16.1% | 1,081,133 | -58.4% | 0.00% | 0.0% |
| Q2 2022 | $19,497,000 | -22.7% | 2,599,748 | -6.2% | 0.00% | 0.0% |
| Q1 2022 | $25,212,000 | +52.6% | 2,770,652 | +17.7% | 0.00% | 0.0% |
| Q4 2021 | $16,524,000 | -44.8% | 2,353,893 | -10.4% | 0.00% | -33.3% |
| Q3 2021 | $29,961,000 | -28.7% | 2,628,097 | +0.1% | 0.00% | -25.0% |
| Q2 2021 | $42,040,000 | -11.6% | 2,625,907 | -1.3% | 0.00% | -20.0% |
| Q1 2021 | $47,536,000 | +17.3% | 2,660,101 | -11.3% | 0.01% | 0.0% |
| Q4 2020 | $40,526,000 | +28.5% | 2,999,726 | +11.9% | 0.01% | +25.0% |
| Q3 2020 | $31,539,000 | -3.9% | 2,679,710 | +20.5% | 0.00% | -20.0% |
| Q2 2020 | $32,830,000 | +64.5% | 2,224,290 | +50.5% | 0.01% | +25.0% |
| Q1 2020 | $19,953,000 | -28.8% | 1,477,980 | +27.4% | 0.00% | 0.0% |
| Q4 2019 | $28,035,000 | +2331.5% | 1,159,914 | +1833.9% | 0.00% | – |
| Q3 2019 | $1,153,000 | +4.5% | 59,978 | +60.8% | 0.00% | – |
| Q2 2019 | $1,103,000 | -89.6% | 37,301 | -83.3% | 0.00% | -100.0% |
| Q1 2019 | $10,604,000 | -32.1% | 223,232 | -48.4% | 0.00% | -33.3% |
| Q4 2018 | $15,611,000 | -58.9% | 432,430 | -30.0% | 0.00% | -50.0% |
| Q3 2018 | $38,019,000 | +27.2% | 617,677 | +39.6% | 0.01% | +20.0% |
| Q2 2018 | $29,888,000 | +15.1% | 442,466 | -7.6% | 0.01% | +25.0% |
| Q1 2018 | $25,967,000 | +664.9% | 478,673 | +742.5% | 0.00% | – |
| Q4 2017 | $3,395,000 | -0.5% | 56,815 | -19.1% | 0.00% | – |
| Q3 2017 | $3,412,000 | +90.2% | 70,197 | +105.7% | 0.00% | – |
| Q2 2017 | $1,794,000 | -33.0% | 34,134 | -42.2% | 0.00% | -100.0% |
| Q1 2017 | $2,677,000 | +2.0% | 59,017 | -14.9% | 0.00% | 0.0% |
| Q4 2016 | $2,625,000 | +12.3% | 69,344 | +12.0% | 0.00% | 0.0% |
| Q3 2016 | $2,337,000 | +108.8% | 61,924 | -2.6% | 0.00% | – |
| Q2 2016 | $1,119,000 | +50.8% | 63,546 | +4.1% | 0.00% | – |
| Q1 2016 | $742,000 | -61.8% | 61,041 | -23.4% | 0.00% | – |
| Q4 2015 | $1,942,000 | +36.9% | 79,739 | -0.4% | 0.00% | – |
| Q3 2015 | $1,419,000 | +70.1% | 80,021 | +69.3% | 0.00% | – |
| Q2 2015 | $834,000 | -71.9% | 47,261 | -50.2% | 0.00% | -100.0% |
| Q1 2015 | $2,973,000 | +345.1% | 94,864 | +315.3% | 0.00% | – |
| Q4 2014 | $668,000 | +33.9% | 22,841 | -5.3% | 0.00% | – |
| Q3 2014 | $499,000 | +49800.0% | 24,113 | +65070.3% | 0.00% | – |
| Q1 2014 | $1,000 | -50.0% | 37 | -63.0% | 0.00% | – |
| Q4 2013 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|